- Global Pharma News & Resources

Global Menopausal Disorder Treatment Market Estimated $17,656.51 Million Growth By 2027||Players-Eli Lilly And Company, Allergan (A Subsidiary Of Abbvie, Inc.), Therapeuticsmd, Inc

Data bridge market research presents a report on Menopausal Disorder Treatment market which enables you to be acquainted for the duration of the growing market. The key players and makes are driving the market within the forecast years of 2020-2027.Menopausal Disorder Treatment market research report can assist to keep a tab on the competitors. It is a good evaluation tool that can be of great use in comparative studies. Businesses can track company’s progress as well as the growth of competitors, by keeping an eye on them. It gets easy to devise business strategies that would keep the business ahead of the rivals. This market report can help minimize loss in the business. It not only helps in identifying new business opportunities, but also helps in designing marketing campaigns that will directly target the interest of potential consumers and help in increasing sales.

Global menopausal disorder treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.4% in the forecast period of 2020 to 2027 and is expected to reach USD 17,656.51 million by 2027.

Get Free Full PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @

Key Market Competitors Covered in the Report

  • Eli Lilly and Company,
  • Allergan (A Subsidiary of AbbVie, Inc.),
  • TherapeuticsMD, Inc.,
  • GlaxoSmithKline plc
  • Reddy’s Laboratories Ltd.
  • Ipsen Pharma, Pfizer Inc.
  • Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
  • Mylan N.V.
  • Abbott
  • Besins Healthcare
  • Mithra Pharmaceuticals
  • Aché Laboratórios Farmacêuticos S.A

Global Menopausal Disorder Treatment Market Scenario

According to Data Bridge Market Research, the market for global menopausal disorder treatment in North America has the highest market share. Market leader is Pfizer Inc. which accounts an estimated market share of approximately 14.93%. The company has gained outstanding sale by providing advanced menopausal disorder treatment medicines.

In December 2018, Pfizer Inc. and GlaxoSmithKline PLC signed an agreement to form a new consumer healthcare joint venture. As the company is focused on manufacturing of prescription medicines involving hormonal therapies used for menopausal disorder treatment this initiative helped it to strengthen its pharmaceutical product portfolio.

To Understand How Covid-19 Impact Is Covered In This Report, Get Free Covid-19 Sample @

New Market Developments

In May 2019, Novartis AG received FDA approval for Piqray to use with fulvestrant for treatment of post-menopausal disorders in women who suffered breast cancer. This product approval enhanced the company’s product portfolio and helped it to generate more revenue.

In July 2017, Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.) has launched generic Vagifem in the U.S. market. This is an estradiol vaginal insert used for treatment for atrophic vaginitis associated with menopause. This product launch helped the company to boost the company’s generic product portfolio and helped it to penetrate its root in menopausal disorder treatment market.

Segmentation:Global Menopausal Disorder Treatment Market

Menopausal Disorder Treatment Market By Stages

(Menopause, Postmenopause, Perimenopause),

Menopausal Disorder Treatment Market By Type

(Hormonal Therapy and Non-Hormonal Therapy),

Menopausal Disorder Treatment Market By Menopause Symptoms

(Vasomotor Symptoms, Atrophic Vaginitis, Osteoporosis, Joint Pain, Weight Gain, Dyspareunia, Depression, Others),

Menopausal Disorder Treatment Market By Dosage Form

(Tablet, Creams, Gels, Rings/Insert, Patch/Film, Injection Shot, Spray, Others),

Menopausal Disorder Treatment Market By Route of Administration

(Oral, Vaginal, Transdermal, Parenteral),

Menopausal Disorder Treatment Market By End User

(Hospital, Clinics, Home Healthcare), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy),

Menopausal Disorder Treatment Market By Country

(U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa)

Make an Inquiry of the Menopausal Disorder Treatment Market Report @

Geographical Base of Global Menopausal Disorder Treatment Control Market:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Core Objectives Of Menopausal Disorder Treatment Market Research

  • To analyze global Menopausal Disorder Treatment status, future forecast, growth opportunity, key market and key players.
  • To present the Menopausal Disorder Treatment development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

Reasons To Purchase Menopausal Disorder Treatment Market Report Covered:

  • The report examines how Menopausal Disorder Treatment market will develop in the future.
  • Studying various views of the Menopausal Disorder Treatment market with the help of Porter’s five forces analysis.
  • Analyzing the product type that is probably to control the market and regions that are likely to witness the fastest development during the forecast period
  • Identify the new developments, Menopausal Disorder Treatment market shares and strategies employed by the key market players.
  • Competitive landscape including the market share of major players along with the key strategies accepted for growth in the past five years
  • Complete company profiles covering the product offerings, key financial information, current developments, SWOT analysis and strategies employed by the major Menopausal Disorder Treatment market players

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 28-Jan-2021